Skip to content

2023 February 2 release
Compare
Choose a tag to compare
@brendanreardon brendanreardon released this 02 Feb 16:32
· 16 commits to main since this release
v.2023-02-02
fa519f4
This commit was created on GitHub.com and signed with GitHub’s verified signature. The key has expired.
GPG key ID: 4AEE18F83AFDEB23
Expired
Learn about vigilant mode.

In this release, we add two recent precision oncology approvals from the FDA regarding ER signaling inhibition in two cancer types.

Added entries:

  • (FDA) ERBB2 copy number amplifications and sensitivity to trastuzumab in combination with tucatinib in colorectal cancer.
  • (FDA) ESR1 somatic variants and sensitivity to elacestrant in breast cancer.
Assets 2
Loading